Options for diagnosing and treating glaucoma have advanced considerably in recent years. One expert explores these advances.
Here’s why telemedicine could increase screening of retinopathy of prematurity.
Two experts discuss the potential of two recently approved drugs for open-angle glaucoma.
The American Board of Ophthalmology says it plans to make Quarterly Questions the new standard for board certification.
This weekly news roundup is brought to our readers by our partners at Ophthalmology Times, which is a part of UBM Medica. (Free registration is required.)